On the 18th of August 2015, the FDA approved a drug called Addyi (flibanserin). Addyi was specifically developed to treat pre-menopausal women who have been diagnosed with generalised hypoactive ...
USA: A recent study has shed light on the effectiveness of flibanserin in addressing Hypoactive Sexual Desire Disorder (HSDD) in women, revealing promising improvements across multiple dimensions of ...
Some people may be taking Viagra as an off-label drug for low female sex drive. Other Viagra-like drugs for women include Addyi (flibanserin) and Vyleesi (bremelanotide). All three drugs require a ...
Flibanserin, the brand name for which is Addyi, has been approved by the Food and Drug Administration only for premenopausal women. Clinical studies show that after eight to 12 weeks it does boost the ...
is a first-in-class melanocortin 4 receptor agonist originally developed by Palatin Technologies and is the second drug to be approved by the FDA after Addyi (flibanserin) for hypoactive sexual ...
will talk about the U.S. Food and Drug Administration's approval of Addyi and what that means for women's health. Also know as flibanserin, this drug is used to treat hypoactive sexual desire ...